BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15180734)

  • 21. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
    Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
    Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Henneken M; Dörner T; Burmester GR; Berek C
    Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma.
    Wu LQ; Lu Y; Wang XF; Lv ZH; Zhang B; Yang JY
    Life Sci; 2006 Jul; 79(8):744-8. PubMed ID: 16546222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
    Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
    J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma.
    Kawata A; Une Y; Hosokawa M; Uchino J; Kobayashi H
    Jpn J Clin Oncol; 1992 Aug; 22(4):256-63. PubMed ID: 1331571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression levels of CXC chemokine receptors 3 are associated with clinical phenotype of type 1 diabetes.
    Yamada S; Oikawa Y; Sakai G; Atsumi Y; Maruyama T; Shimada A
    Ann N Y Acad Sci; 2006 Oct; 1079():186-9. PubMed ID: 17130553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nickel-responding T cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10.
    Moed H; Boorsma DM; Stoof TJ; von Blomberg BM; Bruynzeel DP; Scheper RJ; Gibbs S; Rustemeyer T
    Br J Dermatol; 2004 Jul; 151(1):32-41. PubMed ID: 15270870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma.
    Mühlbauer M; Ringel S; Hartmann A; Lallinger G; Weiss TS; Gäbele E; Wünsch PH; Schölmerich J; Hellerbrand C
    Oncol Rep; 2005 May; 13(5):957-63. PubMed ID: 15809764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered chemokine receptor profile on circulating leukocytes in human heart failure.
    Athanassopoulos P; Vaessen LM; Balk AH; Weimar W; Sharma HS; Bogers AJ
    Cell Biochem Biophys; 2006; 44(1):83-101. PubMed ID: 16456237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis.
    Wedderburn LR; Robinson N; Patel A; Varsani H; Woo P
    Arthritis Rheum; 2000 Apr; 43(4):765-74. PubMed ID: 10765921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of CD28 coincides with the down-modulation of CD3zeta and augmentation of caspase-3 activity in T cells from hepatocellular carcinoma-bearing patients and hepatitis C virus-infected patients.
    Maki A; Matsuda M; Asakawa M; Kono H; Fujii H; Matsumoto Y
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1348-56. PubMed ID: 15610307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokine C receptor 7 expression and protection of circulating CD8+ T lymphocytes from apoptosis.
    Kim JW; Ferris RL; Whiteside TL
    Clin Cancer Res; 2005 Nov; 11(21):7901-10. PubMed ID: 16278415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of AFPmRNA and melanoma antigen gene-1mRNA as markers of disseminated hepatocellular carcinoma cells in blood.
    Yang SZ; Dong JH; Li K; Zhang Y; Zhu J
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):227-33. PubMed ID: 15908320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials].
    Xue TC; Chen RX; Ye SL; Sun RX; Chen J; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):261-5. PubMed ID: 17456312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma.
    Yuen MF; Norris S
    Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma.
    Uchida H; Iwashita Y; Sasaki A; Shibata K; Matsumoto T; Ohta M; Kitano S
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):161-8. PubMed ID: 16706828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
    J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.